跳至主要内容
临床试验/IRCT20201016049048N1
IRCT20201016049048N1招募中早期 1 期

Evaluation of the effectiveness of Iranian Borage Aerial Part infusion on the management of Covid-19 mild to moderate symptoms: a clinical trial

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
早期 1 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with COVID-19 confirmed by RT-PCR and Ground glass view on CT scan
  • Patients with COVID-19 symptoms (such as fever, muscle pain, chest discomfort, cough, reduced CBC and platelets, increased CRP and ESR) who have been exposed to suspected people in the last 14 days
  • Having a conscious consent form signed to participate in the study
  • Not participating in similar studies at the same time

排除标准

  • People with a history of allergy to herbal medicines
  • Having liver, kidney and cardiovascular diseases
  • Permanent use of psychiatric drugs
  • Pregnant and breastfeeding women
  • People who can't swallow
  • Having endocrine diseases like diabetes

研究者

相似试验